Andreozzi F, Raciti GA, Nigro C, Mannino GC, Procopio T, Davalli AM, Beguinot F, Sesti G, Miele C, Folli F (2016) The GLP-1 receptor agonists exenatide and liraglutide activate glucose transport by an AMPK-dependent mechanism. J Transl Med 14(1):229. https://doi.org/10.1186/s12967-016-0985-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Apelt J, Mehlhorn G, Schliebs R (1999) Insulin-sensitive GLUT4 glucose transporters are colocalized with GLUT3-expressing cells and demonstrate a chemically distinct neuron-specific localization in rat brain. J Neurosci Res 57(5):693–705

CAS  PubMed  Google Scholar 

Babic Perhoc A, Osmanovic Barilar J, Knezovic A, Farkas V, Bagaric R, Svarc A, Grunblatt E, Riederer P, Salkovic-Petrisic M (2019) Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice. Neuropharmacology 148:50–67. https://doi.org/10.1016/j.neuropharm.2018.12.018

Article  CAS  PubMed  Google Scholar 

Badawi GA, Abd El Fattah MA, Zaki HF, El Sayed MI (2017) Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson’s disease. Inflammopharmacology 25(3):369–382. https://doi.org/10.1007/s10787-017-0331-6

Article  CAS  PubMed  Google Scholar 

Bassani TB, Bonato JM, Machado MMF, Coppola-Segovia V, Moura ELR, Zanata SM, Oliveira R, Vital M (2018) Decrease in adult neurogenesis and neuroinflammation are involved in spatial memory impairment in the streptozotocin-induced model of sporadic Alzheimer’s disease in rats. Mol Neurobiol 55(5):4280–4296. https://doi.org/10.1007/s12035-017-0645-9

Article  CAS  PubMed  Google Scholar 

Batista AF, Forny-Germano L, Clarke JR, Lyra ESNM, Brito-Moreira J, Boehnke SE, Winterborn A, Coe BC, Lablans A, Vital JF, Marques SA, Martinez AM, Gralle M, Holscher C, Klein WL, Houzel JC, Ferreira ST, Munoz DP, De Felice FG (2018) The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer’s disease. J Pathol 245(1):85–100. https://doi.org/10.1002/path.5056

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bavarsad K, Hadjzadeh MA, Hosseini M, Pakdel R, Beheshti F, Bafadam S, Ashaari Z (2020) Effects of levothyroxine on learning and memory deficits in a rat model of Alzheimer’s disease: the role of BDNF and oxidative stress. Drug Chem Toxicol 43(1):57–63. https://doi.org/10.1080/01480545.2018.1481085

Article  CAS  PubMed  Google Scholar 

Blokland A, Jolles J (1993) Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin. Pharmacol Biochem Behav 44(2):491–494. https://doi.org/10.1016/0091-3057(93)90497-h

Article  CAS  PubMed  Google Scholar 

Blokland A, Jolles J (1994) Behavioral and biochemical effects of an ICV injection of streptozotocin in old Lewis rats. Pharmacol Biochem Behav 47(4):833–837. https://doi.org/10.1016/0091-3057(94)90284-4

Article  CAS  PubMed  Google Scholar 

Bondi MW, Edmonds EC, Salmon DP (2017) Alzheimer’s disease: past, present, and future. J Int Neuropsychol Soc 23(9–10):818–831. https://doi.org/10.1017/S135561771700100X

Article  PubMed  PubMed Central  Google Scholar 

Brewer PD, Habtemichael EN, Romenskaia I, Mastick CC, Coster AC (2014) Insulin-regulated Glut4 translocation: membrane protein trafficking with six distinctive steps. J Biol Chem 289(25):17280–17298. https://doi.org/10.1074/jbc.M114.555714

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buganova M, Pelantova H, Holubova M, Sediva B, Maletinska L, Zelezna B, Kunes J, Kacer P, Kuzma M, Haluzik M (2017) The effects of liraglutide in mice with diet-induced obesity studied by metabolomics. J Endocrinol 233(1):93–104. https://doi.org/10.1530/JOE-16-0478

Article  CAS  PubMed  Google Scholar 

Cardoso S, Correia S, Santos RX, Carvalho C, Santos MS, Oliveira CR, Perry G, Smith MA, Zhu X, Moreira PI (2009) Insulin is a two-edged knife on the brain. J Alzheimers Dis 18(3):483–507. https://doi.org/10.3233/JAD-2009-1155

Article  CAS  PubMed  Google Scholar 

Chen ZY, Zhang Y (2022) Animal models of Alzheimer’s disease: applications, evaluation, and perspectives. Zool Res 43(6):1026–1040. https://doi.org/10.24272/j.issn.2095-8137.2022.289

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Gao L, Zhang Y, Su Y, Kong Z, Wang D, Yan M (2021) Acteoside-improved streptozotocin-induced learning and memory impairment by upregulating hippocampal insulin, glucose transport, and energy metabolism. Phytother Res 35(1):392–403. https://doi.org/10.1002/ptr.6811

Article  CAS  PubMed  Google Scholar 

Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer’s disease? Ageing Res Rev 10(2):264–273. https://doi.org/10.1016/j.arr.2011.01.001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dendorfer U, Oettgen P, Libermann TA (1994) Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol 14(7):4443–4454. https://doi.org/10.1128/mcb.14.7.4443-4454.1994

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng Y, Li B, Liu Y, Iqbal K, Grundke-Iqbal I, Gong CX (2009) Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: implication for Alzheimer’s disease. Am J Pathol 175(5):2089–2098. https://doi.org/10.2353/ajpath.2009.090157

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deuschl G, Beghi E, Fazekas F, Varga T, Christoforidi KA, Sipido E, Bassetti CL, Vos T, Feigin VL (2020) The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017. Lancet Public Health 5(10):e551–e567. https://doi.org/10.1016/S2468-2667(20)30190-0

Article  PubMed  Google Scholar 

Dineley KT, Jahrling JB, Denner L (2011) Insulin resistance in Alzheimer’s disease. Neurobiol Dis 72:92–103. https://doi.org/10.1016/j.nbd.2014.09.001

Article  CAS  Google Scholar 

Diz-Chaves Y, Mastoor Z, Spuch C, Gonzalez-Matias LC, Mallo F (2022) Anti-inflammatory effects of GLP-1 receptor activation in the brain in neurodegenerative diseases. Int J Mol Sci. https://doi.org/10.3390/ijms23179583

Article  PubMed  PubMed Central  Google Scholar 

Duelli R, Schrock H, Kuschinsky W, Hoyer S (1994) Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int J Dev Neurosci 12(8):737–743. https://doi.org/10.1016/0736-5748(94)90053-1

Article  CAS  PubMed  Google Scholar 

Duffy AM, Holscher C (2013) The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer’s disease. Neuroscience 228:294–300. https://doi.org/10.1016/j.neuroscience.2012.10.045

Article  CAS  PubMed  Google Scholar 

van Duijn CM, Hofman A, Nagelkerken L (1990) Serum levels of interleukin-6 are not elevated in patients with Alzheimer’s disease. Neurosci Lett 108(3):350–354. https://doi.org/10.1016/0304-3940(90)90666-w

Article  PubMed  Google Scholar 

Erta M, Quintana A, Hidalgo J (2012) Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8(9):1254–1266. https://doi.org/10.7150/ijbs.4679

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferreira ST, Clarke JR, Bomfim TR, De Felice FG (2014) Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer’s disease. Alzheimers Dement 10(1 Suppl):S76-83. https://doi.org/10.1016/j.jalz.2013.12.010

Article  PubMed  Google Scholar 

Ferreira LSS, Fernandes CS, Vieira MNN, De Felice FG (2018) Insulin resistance in Alzheimer’s disease. Front Neurosci 12:830. https://doi.org/10.3389/fnins.2018.00830